Nothing Special   »   [go: up one dir, main page]

DK1280784T3 - Biologisk aktive 4H-benzo[1,4]oxazin-3-oner - Google Patents

Biologisk aktive 4H-benzo[1,4]oxazin-3-oner

Info

Publication number
DK1280784T3
DK1280784T3 DK01937335T DK01937335T DK1280784T3 DK 1280784 T3 DK1280784 T3 DK 1280784T3 DK 01937335 T DK01937335 T DK 01937335T DK 01937335 T DK01937335 T DK 01937335T DK 1280784 T3 DK1280784 T3 DK 1280784T3
Authority
DK
Denmark
Prior art keywords
oxazin
benzo
ones
biologically active
biologically
Prior art date
Application number
DK01937335T
Other languages
English (en)
Inventor
Thomas P Burris
Donald W Combs
Philip J Rybczynski
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1280784T3 publication Critical patent/DK1280784T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings
    • C07F9/65335—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01937335T 2000-05-12 2001-05-11 Biologisk aktive 4H-benzo[1,4]oxazin-3-oner DK1280784T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20386000P 2000-05-12 2000-05-12
US09/854,302 US6555536B2 (en) 2000-05-12 2001-05-11 Biologically active 4H-benzo [1,4]oxazin-3-ones
PCT/US2001/015383 WO2001087862A2 (en) 2000-05-12 2001-05-11 Biologically active 4h-benzo[1,4]oxazin-3-ones

Publications (1)

Publication Number Publication Date
DK1280784T3 true DK1280784T3 (da) 2007-10-29

Family

ID=26898967

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01937335T DK1280784T3 (da) 2000-05-12 2001-05-11 Biologisk aktive 4H-benzo[1,4]oxazin-3-oner

Country Status (12)

Country Link
US (1) US6555536B2 (da)
EP (1) EP1280784B1 (da)
AR (1) AR033375A1 (da)
AT (1) ATE365725T1 (da)
AU (1) AU2001263083A1 (da)
CY (1) CY1106863T1 (da)
DE (1) DE60129123T2 (da)
DK (1) DK1280784T3 (da)
ES (1) ES2288957T3 (da)
MY (1) MY141659A (da)
PT (1) PT1280784E (da)
WO (1) WO2001087862A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US6908908B2 (en) 2000-05-12 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4H-benzo [1,4] oxazin-3-ones
HU230352B1 (hu) * 2001-06-12 2016-02-29 Wellstat Therapeutics Corporation Metabolikus rendellenességek kezelésére adható vegyületek és ezeket tartalmazó gyógyászati készítmények
US7041693B2 (en) 2002-10-04 2006-05-09 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
WO2006057448A1 (ja) * 2004-11-26 2006-06-01 Takeda Pharmaceutical Company Limited アリールアルカン酸誘導体
KR20080098615A (ko) * 2006-02-28 2008-11-11 웰스태트 테러퓨틱스 코포레이션 물질대사 장애의 치료용 화합물
EP2061442B1 (en) 2006-09-08 2016-08-31 Rhode Island Hospital Treatment, prevention, and reversal of alcohol-induced brain disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
BR9508468A (pt) 1994-07-29 1997-11-25 Smithkline Beecham Plc Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário
JPH0912575A (ja) * 1995-06-28 1997-01-14 Sankyo Co Ltd ベンゾオキサジンおよびベンゾチアジン誘導体
US5696117A (en) * 1995-11-07 1997-12-09 Ortho Pharmaceutical Corporation Benzoxazine antimicrobial agents
US5707990A (en) * 1996-01-30 1998-01-13 Ortho Pharmaceutical Corporation 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
PL341795A1 (en) * 1998-05-27 2001-05-07 Reddy Research Foundation Bicycle compounds, process for obtaining them and pharmacological compositions containing such compounds

Also Published As

Publication number Publication date
WO2001087862A2 (en) 2001-11-22
EP1280784A2 (en) 2003-02-05
US6555536B2 (en) 2003-04-29
DE60129123T2 (de) 2008-02-28
WO2001087862A3 (en) 2002-05-30
AU2001263083A1 (en) 2001-11-26
CY1106863T1 (el) 2012-09-26
AR033375A1 (es) 2003-12-17
EP1280784B1 (en) 2007-06-27
DE60129123D1 (de) 2007-08-09
ATE365725T1 (de) 2007-07-15
PT1280784E (pt) 2007-09-03
ES2288957T3 (es) 2008-02-01
MY141659A (en) 2010-05-31
US20020165228A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
DE60111734D1 (de) [1,4']-bipiperidin verbindungen
PT1379511E (pt) Derivados de di-hidro-benzo[b] [1,4] diazepin-2-ona como antagonistas ii de r2glum
NO20024170L (no) Forminsket, nållös injektor
BR0005401B1 (pt) artigo absorvente.
PT1379522E (pt) Derivados de di-hidro-benzo[b] [1,4] diazepina-2-ona como antagonistas i do r2glum
FR2810863B3 (fr) Structure de support d'articles
ID28483A (id) 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
DE69936153D1 (de) Biologischaktive Labdan- oder Labdenderivate aus Cistus.
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
NO20030868D0 (no) N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
NO20016147L (no) Biologiske aktive materialer
ITTO20000385A0 (it) Composizione pesticida.
DK1280784T3 (da) Biologisk aktive 4H-benzo[1,4]oxazin-3-oner
DK1149106T3 (da) 4,5-azolo-oxindoler
NO20026086L (no) Transgent produsert plateavledet vekstfaktor
ITTO20000386A0 (it) Composizione pesticida.
IT1319526B1 (it) Macchina i.s.
EG23084A (en) Optically active 2,5-bisaryl-delta1-pyrrolines
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
DE50109598D1 (de) Spulenwechseleinrichtung
IT1319528B1 (it) Macchina i.s.
ITMI20001734A0 (it) 1,3-diossolani ad attivita' antitosse
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas